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ABSTRACT 
Background: The comprehension of the mechanism of action of antimicrobial peptides 
is fundamental for the design of new antibiotics. Studies performed looking at the 
interaction of peptides with bacterial cells offer a faithful picture of what really happens 
in nature. 
Methods: In this work we focused on the interaction of the peptide Temporin L with E. 
coli cells, using a variety of biochemical and biophysical techniques that include: 
functional proteomics, docking, optical microscopy, TEM, DLS, SANS, fluorescence. 
Results: We identified bacterial proteins specifically interacting with the peptides that 
belong to the divisome machinery; our data suggest that the GTPase FtsZ is the specific 
peptide target. Docking experiments supported the FtsZ-TL interaction; binding and 
enzymatic assays using recombinant FtsZ confirmed this hypothesis and revealed a 
competitive inhibition mechanism. Optical microscopy and TEM measurements 
demonstrated that, upon incubation with the peptide, bacterial cells are unable to divide 
forming long necklace-like cell filaments. Dynamic light scattering studies and Small 
Angle Neutron Scattering experiments performed on treated and untreated bacterial 
cells, indicated a change at the nanoscale level of the bacterial membrane 
Conclusions: The peptide temporin L acts by a non-membrane-lytic mechanism of 
action, inhibiting the divisome machinery. 
General significance: Identification of targets of antimicrobial peptides is pivotal to the 
tailored design of new antimicrobials 
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INTRODUCTION 
The growing demand of new antibiotics active against multi-resistant bacteria has 
encouraged the research of antimicrobial agents from natural sources. Peptides are the 
most common weapon that organisms from all domains of life produce to prevent the 
invasion by external pathogens. Antimicrobial peptides (AMPs) are short peptides 
consisting of 10-50 amino acids, often containing multiple hydrophobic and positively 
charged residues .[1] Unlike common antibiotics, AMPs, alone and in combination with 
other antibiotics, are less prone to trigger resistance or transient cross-resistance and 
mainly act against bacterial cells.[2, 3] 
However, the possible exploitation of AMPs as new antibacterial drugs is strictly 
dependent on a clear description of their mechanism of action at the molecular level. 
Several studies focused on the interaction of antimicrobial peptides with Gram negative 
bacterial cells contributed to clarify some details on the mechanism of action of AMP. 
[4] 
These studies indicated the chemical /physical features of bacteria and peptides that are 
fundamental for their interactions and which pathways, essential for the bacterial cell 
life, are affected by AMPs. Fluorescence microscopy studies on E. coli cells revealed 
that the kinetic of bacterial cell death is related to the composition of the 
lipopolysaccharide (LPS).[5] The interaction of peptides with LPS often triggers the 
folding of peptides.[6, 7] Peptides saturate the outer membrane of bacteria, determining 
its neutralization, as revealed by Z potential measurements.[8, 9] Recently, single cell 
time-resolved fluorescence microscopy studies suggested that cationic AMPs initially 
permeabilize the outer membrane (OM) enabling a rapid access of the peptide to the 
periplasm. As the concentration of the peptide in the periplasm grows, the same process 
occurs to the cytoplasmic membrane, which is permeabilized only after the outer 
membrane is resealed, allowing AMPs to travel into the cytoplasm and generating a 
variety of possible damaging events downstream.[10] 
Protein targets of AMPs are currently deeply investigated, and it is now clear that 
different peptides may have different targets.[11-13] Processes that have been found to 
be hampered by AMPs include bacterial cell division and outer membrane biogenesis. 
Inhibition of cell division is suggested when bacterial cells form elongated structures in 
the presence of antimicrobial peptides. Studies on the peptide C18G demonstrated that it 
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impairs cell division in E. coli by interacting with the transmembrane protein PhoQ that 
phosphorylates PhoP triggering the over-expression of the protein QueE that in turn 
blocks the divisome complex.[14] Inhibition of outer membrane biogenesis yields 
defects in the architecture of the membrane. A combination of fluorescence microscopy, 
mass spectrometry and bioinformatics analyses demonstrated that the peptide thanatin 
affects the LPS transport machinery by interacting with both the periplasmic protein 
LptA and the outer membrane protein LptD.[13] 
LptD was also identified as the target of the peptidomimetic L27-11, which is 
specifically active on P. aeruginosa.[15] Furthermore, a 15 amino-acid peptide 
fragment derived from BamA was demonstrated to have potent antibiotic activity being 
able to bind BamD, that is part of the complex devoted to the assembly of beta barrel 
proteins in the outer membrane of E. coli .[11] These results suggest that AMPs may 
interact with either bacterial membrane or specific intracellular protein targets thus 
affecting cellular mechanisms and that a deeper investigation is essential for the 
definition of their effect on vital cellular processes. 
We investigated the mechanism of action of the peptide Temporin L (TL) a natural 
peptide secreted from the skin of the European frog Rana temporaria active against 
Gram positive and Gram-negative bacteria on E. coli cells.[16] This peptide interacts 
with E. coli LPS, in vitro and in vivo [17-19]; however, its mechanism of action has not 
been clarified. Perturbation of the bacterial membrane that occurs at TL low 
concentrations is not the lethal event for bacterial cells; this observation leads to the 
hypothesys that killing of bacterial cells is mediated by the interaction of the peptide 
with an intracellular target. Functional Proteomic experiments indicated a specific 
interaction of TL with proteins belonging to the divisome complex. Sequence homology 
alignment with other AMPs suggested a possible direct interaction with the GTPase 
FtsZ. Docking experiments supported the FtsZ-TL interaction that was clearly 
demonstrated by binding and enzymatic assays using recombinant FtsZ revealing a 
competitive inhibition mechanism. Optical microscopy and TEM measurements 
demonstrated that, upon incubation with the peptide, bacterial cells are unable to divide 
forming long necklace-like cell filaments. Finally, the effect of the peptide on the 
morphology and the structure of bacterial cells at nanoscale level was also investigated 
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by both Ultra Small-Angle Neutron Scattering (USANS) and Small-Angle Neutron 
Scattering (SANS). 
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RESULTS 
 
Effect of Temporin L on E. coli cell growth 
The antimicrobial activity of TL was verified by monitoring E. coli cell growth in the 
presence of different concentrations of TL. The MIC was calculated to be 32 µM, in 
agreement with literature data.[16] (Supplementary Figure 1)   
 
Pull-Down experiment 
A detailed investigation of the mechanism of action of TL at the molecular level was 
pursued by functional proteomics approaches. Biotinylated TL was immobilized onto 
streptavidin-conjugated agarose beads and incubated with a membrane protein extract 
from E. coli cells. The proteins specifically interacting with the peptide bait were eluted 
and fractionated by SDS-PAGE. A membrane protein extract was also incubated with 
streptavidin-conjugated agarose beads lacking the peptide and the eluted proteins were 
used as control. Protein bands from sample and control lanes were excised from the gel 
and subjected to in situ hydrolysis with trypsin. The resulting peptide mixtures were 
directly analyzed by LC-MS/MS and the mass spectral data used to search a protein 
database using an in-house version of the Mascot software leading to protein 
identification.Proteins that were identified both in the control and in the sample lanes 
were discarded, whereas those solely occurring in the sample and absent in the control 
were considered as putative TL interactors. 
Figure 1A and B shows the distribution of TL putative protein partners according to 
their cellular localization and the biological processes they are involved into. A 
bioinformatic analysis was performed using the String software and the KEGG pathway 
showing that a large number of proteins gathered within a network involved in cell 
division and the biosynthesis of peptidoglycan for the production of the division septum 
(Figure 1C).  
In particular, several proteins belonging to the divisome complex were identified 
including FtsZ, FtsA, MurG, MukB and MreB.  
Among these proteins, FtsZ protein, is a bacterial tubulin homolog and is responsible of 
the Z ring formation, the first step in the formation of the divisome complex, which is 
responsible of the cell division. Recently, FtsZ was reported to be the target of two 
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peptides, CRAMP (16-33) and MciZ .[12] Sequence alignment showed that TL shares a 
high sequence homology to the C-terminal portion of both CRAMP (16-33) and MciZ 
(Figure 2A). This observation urged us to investigate the interaction of TL with FtsZ in 
vitro and in vivo and to develop a molecular model of the peptide-protein interaction by 
docking calculations. 
 
 
 
 
Figure 1. (A) Distribution of TL putative protein partners identified in the pull-down 
experiment according to their cellular localization. and biological functions. (B) 
Distribution of TL putative protein partners according to their biological functions. (C) 
STRING analysis of the putative TL interactors belonging to the divisome complex 
showing the occurrence of a network including 8 proteins: FtsZ, FtsA, MurG, MukB, 
Rho, DacA, pea and MreB. 
 
Docking experiments 
The putative structural basis of the binding of TL to FtsZ were investigated by a 
docking study (Figure 2B). Calculations reveal that TL may bind the cavity that allows 
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the accommodation of GDP in the structures of FtsZ from B. subtilis and P. aeruginosa 
(Figure 2C), thus suggesting a possible competitive inhibition of the peptide for the 
GTPase activity of the protein. A detailed analysis of the interactions at the 
protein/peptide interface suggests the involvement of hydrophobic and coulombic 
interactions, with Phe and Trp residues of the peptide that pack against residues Gly20, 
Gly21, Gly71, Ala72, Gly105, Gly106, Gly107 and Phe182 of the protein and with the 
side chain of the Arg of the peptide that could make a salt bridge with the side chain of 
Glu138 of Ftsz (Figure 2D). 
 
 
 
 
 
 
Figure 2. (A) Sequence alignment of peptides Temporin L, CRAMP 16-33 and MciZ. 
(B)	  The predicted structure of the complex between FtsZ (yellow) and TL (cyan). (C) 
Putative binding site well superimposes to that of GDP in the structures of B. subtilis 
and P. aeruginosa FtsZ. (D)	   Predicted binding site of TL (cyan) on FtsZ structure 
(yellow).  
 
Binding experiments 
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As docking calculations suggested a possible interaction between TL and FtsZ, we were 
stimulated to confirm the binding of the peptide TL to the protein FtsZ on experimental 
basis. A recombinant form of FtsZ was produced in E. coli, purified and used in binding 
and enzymatic assays. Fluorescence experiments were carried out using the peptide 
labeled at the N-terminus with fluoresceine incubated with increasing concentrations of 
the protein (Figure 3A). Data from Fig. 3A allowed us to calculate a Kd value of 17.4± 
0.8 nM.  
 
Enzymatic assays 
To further validate the docking predictions and to study the effect of TL on FtsZ, the 
GTPase activity of the recombinant protein was assayed in the absence and in the 
presence of TL. The purified recombinant protein was incubated with GTP in the 
presence of the peptide (35 µM) and the GTPase activity of FtsZ was monitored in 
comparison with the untreated protein at different GTP concentrations. In the presence 
of TL a decrease in the enzymatic activity of FtsZ was clearly observed confirming a 
specific interaction of the peptide with FtsZ (Fig. 3B). Kinetic parameters were 
calculated showing an increase of the apparent KM by about 50% (112.0 µM as 
compared to 56.6µM in the absence of the peptide) whereas Vmax remained unchanged, 
demonstrating the competitive inhibitory mechanism exerted by TL on FtsZ. The half-
maximal inhibitory concentration (IC50) of TL on the GTPase activity of FtsZ was also 
calculated resulting as 62 ±2 µM (Fig. 3C), slightly lower than the IC50 determined for 
CRAMP (16-33) (16).  
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Figure 3.  
(A) Binding of TL to FtsZ as determined by fluorescence experiments using N-terminal 
fluoresceine-labelled TL and recombinant FtsZ. (B) Enzymatic activity of recombinant 
FtsZ in the absence and in the presence of 35 µM TL using GTP as substrate. (C) 
Determination of TL IC50, i.e. the minimal peptide concentration displaying 50% 
inhibition of FtsZ GTPase activity. 
 
 
Optical microscopy and TEM analyses 
The morphologic effect of FtsZ inhibition by TL on cell division was investigated in 
vivo by both optical microscopy measurements and TEM analyses. on E. coli cell 
cultures grown in the presence and in the absence of the peptide. Optical microscopy 
images clearly show that in the presence of TL (Fig. 4B) E. coli cells form long 
necklace-like structures containing a large number of E. coli cells originated by 
impairment in cell division that were absent in the control (Fig. 4A). When the same 
experiment was carried out in the presence of 1mM GTP, an almost completely rescue 
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of the phenotype was observed as indicated by the large decrease in both the number 
and the length of the necklace-like strucures (Fig. 4C). Accordingly, we evaluated the 
minimal inhibitory concentration (MIC) of TL on E.coli cells in the presence of 1mM 
GTP. MIC greasily increased to 256 µM confirming that the presence of GTP might 
revert the TL effect. 
 
 
 
 
 
 
 
 
 
Figure 4. Optical microscopy images of E. coli cells grown in the absence (panel A) 
and in the presence (panel B) of 20 µM TL. Long necklace-like structures formed by E. 
coli cells were clearly detected in the presence of the peptide confirming the impairment 
of bacterial cell division. The phenotype was rescued in the presence of 1mM GTP that 
restored cell division (panel C). 
 
The TL effect on E. coli cells growth was also investigated by TEM analyses. TEM 
images shown in Fig 5B confirmed that, following treatment with TL, bacterial cells 
division was impaired as indicated by several cells bound together and unable to divide 
when compared to the control (Fig. 5A). No damage of membranes was detected and 
the cells appeared turgid.  
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Figure 5. TEM analysis of E. coli cells grown in the absence (panel A) and in the 
presence (panel B) of 20 µM TL. TEM images further confirmed the occurrence of 
bacterial cells unable to divide in the presence of TL (panel B) as compared to the 
control (panel A). 
 
Spectroscopic investigations 
The large structures formed by E. coli cells upon treatment with TL were further 
investigated by static light scattering experiments. As shown in Fig. 6, at small values of 
the scattering vector q, in the range probed by the LS, the scattering intensity profile 
decays with a q-1 power low for the sample of E. coli cells in the presence of TL, 
whereas it remains essentially constant for the pure bacteria, i.e for the cells in the 
absence of the peptide. This suggests that, in the presence of TL, large elongated 
structures are formed with a length larger than 6000 nm, the limit of LS instrument. 
SANS analysis revealed that a significant difference between untreated and treated E. 
coli cells occurs in the range between 20 nm (q= 0.001 A-1) and 60 nm (q = 0.003 A-1). 
In such range, the profile of the scattering intensity of E. coli cells changes drastically 
upon TL addition. In the presence of the peptide, the scattering intensity is higher than 
that collected for the system containing only the bacterial cells. Furthermore, in this 
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later a shoulder in the I(q) vs q is present, whereas in the system containing TL the 
shoulder disappears and the scattering intensity decreases with a greater slope. 
 
 
 
Figure 6. Dynamic Light Scattering (LS), USANS, and SANS analyses of E. coli cells 
in the absence (black points) and in the presence (red points) of 20 µM TL. LS 
measurements showed a decrease of the intensity with a q-1 power law for the treated 
sample, whereas this value remained essentially constant for the untreated sample. 
 
 
DISCUSSION 
 
Elucidation of the mechanism of action of antimicrobial peptides requires the 
identification of the peptide targets in bacterial cells. We investigated the mechanism of 
action of Temporin L by a functional proteomic approach based on pull-down 
experiments using a biotinylated version of the peptide as a bait to identify its specific 
protein targets in E. coli. It is well known that in the cell many processes are governed 
by the rapid and transient association of proteins in multicomponent functional 
complexes.[20-22] In bacterial membranes, several proteins are embedded in complexes 
with cytoplasmic proteins. For example, the protein machine devoted to the transport of 
LPS spans from the periplasm to the outer membrane. Accordingly, the proteomic 
experiment led to the identification of several proteins belonging to a multicomponent 
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complex extending from the cytoplasm to all three layers of the cell envelope known as 
the divisome complex involved in the cell division process. 
Among the identified proteins, FtsZ, FtsA, MurG, MukB and MreB are known to 
assemble into a tightly regulated cellular machinery operating to safely separate the cell 
into two daughter cells by a two steps mechanism. FtsZ is a bacterial tubulin homolog, 
expressed in either Gram positive and Gram negative cells responsible of the first step 
in the division of bacterial cells. FtsZ polymerizes in filaments using GTP molecules to 
generate a ring-like structure, the Z ring, at the site of division, then recruits other 
proteins to assemble the divisome complex driving the constriction of the cell 
envelope.[12, 23] In E. coli, FtsZ is tethered to the membrane through FtsA. MurG is a 
glycosyltranferase located in the lateral cell wall and at the division site that catalyzes 
the synthesis of peptidoglycan. Den Blaauween et al suggested the involvement of 
MurG in a complex containing several proteins, including FtsA, implicated in cell 
division.[24] Immunoprecipitation experiments demonstrated that MurG is also 
associated with MreB. MreB is essential for the maintenance of cell shape and plays a 
key role in cell division, being recruited to the septum upon direct interaction with FtsZ, 
an interaction functional to Z ring contraction.[25] 
.Recently, two peptides, namely CRAMP 16-33, an antimicrobial peptide found in 
multicellular organisms, and MciZ, a peptide expressed during sporulation of Bacillus 
subtilis reported to be the physiological inhibitor of FtsZ, were demonstrated to interact 
with FtsZ, inhibit bacterial cell division, causing cell death. Docking experiments show 
that CRAMP 16-33 binds to the cavity of the T7 loop of FtsZ, whereas MciZ is 
supposed to compete with GTP for the same binding site on FtsZ.[12] [26] Sequence 
alignment showed that TL displays high sequence similarity with CRAMP and also 
with the N-terminal residues of MciZ. . Based on these data, we investigated the 
possible interaction of TL with FtsZ. Docking simulation revealed that TL may bind 
FtsZ in the GTP binding site, thus suggesting a possible competitive inhibition 
mechanism of the peptide for the GTPase activity of the protein, as observed for MciZ. 
This hypothesis was confirmed by fluorescent binding experiments carried out using 
recombinant FtsZ in the presence of TL. A high binding affinity was detected for TL 
toward FtsZ with a Kd value of 17.4± 0.8 nM, supporting the hypothesis that FtsZ is the 
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specifc target of the peptide. This value is lower as compared to that reported for MciZ 
(0.3±0.1 µM), the physiological inhibitor of FtsZ.[26] 
Functional investigation of the TL effect on FtsZ were then performed both in vitro and 
in vivo. Enzymatic assays aimed at measuring the GTPase activity of the FtsZ in the 
presence of TL confirmed that TL is a competitive inhibitor of the protein, as indicated 
by the docking simulation. Morphologic investigations of E. coli cells in the presence of 
TL by either optical microscopy measurements or TEM analyses revealed the formation 
of largely elongated “necklace-like” structures originated by a moltitude of bacterial 
cells, demonstrating that the presence of the peptide hinders E. coli cells division. TEM 
images showed several cells bound together and unable to divide. Consistent with this 
observation, the results of static light scattering experiments showed the occurrence of 
elongated structures larger than 6000 nm in the presence of TL. 
Analysis of the bacterial cells was also performed by SANS that allows investigation of 
the morphology and the structure at the nanoscale level. In particular, the atom density 
distribution of an object is obtained from the analysis of its neutron scattering intensity 
as function of the scattering vector, q, when illuminated with a neutron beam. Thus, the 
scattering profile provides structural information over a size scale, d, depending on the q 
range, according to d ~ 2π/q. In the present paper, SANS was exploited to investigate 
the effect of TL on E. coli cells, focusing on the structure formed in the range of 2 to 
300 nm. According to the literature there are only a few papers presenting such 
investigation on living cells.[27] 
Neutron scattering measurements discloses a change in the spatial arrangement of the 
protein involved in the interaction suggesting that a protein underwent a structural 
change following incubation with the peptide in agreement with the docking 
calculation. Notably, in the intermediate q range, i.e. the range where structural changes 
on the membrane would be detectable, SANS analyses clearly showed no differences in 
the lamellar structure of E. coli cells, indicating the absence of a destabilization of the 
bacteria membrane.  
Overall our data depicted the following mechanism of action for Temporin L on E. coli 
cells: the peptide crosses the outer membrane of bacteria and specifically binds FtsZ 
inhibiting its GTPase activity by a competitive inhibition mechanism. This event 
impairs bacterial cell division resulting in the formation of long cell filaments, and 
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finally bacterial cell death. Due to its haemolytic activity, Temporin L cannot be 
considered as an effective alternative to common antibiotics, although optimization of 
the peptide properties by subtle modification of its chemical structure can reduce its 
haemolytic activity.[18, 28] However, elucidation of the mechanism of action at the 
molecular level pointed out to FtsZ as a possible good target for the rational design of 
new antibiotics since this protein is responsible for a crucial biological event of bacterial 
life and is absent in humans. 
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MATERIALS AND METHODS 
The Fmoc amino acids used for the peptide synthesis and 2-(1H-7-Azabenzotriazol-1-
yl)-1,1,3,3-tetramethyluronoium hexafluorphosphate (HATU) were purchased from 
IRIS Biotech GMBH. The Rink amide MBHA resin and the activators N-
hydroxybenzotriazole (HOBT) and O-benzotriazole-N,N,N′,N′- tetramethyl-uronium-
hexafluoro-phosphate (HBTU) were purchased from Novabiochem (Gibbstown, NJ, 
USA). Acetonitrile (ACN) was from Romil, dry N,N-dimethylformamide (DMF), 6-
[Fluorescein-5(6)-carboxamido]hexanoic acid, N-(+)-Biotinyl-6-aminohexanoic acid 
and all other reagents were from Sigma Aldrich (MERCK).  
Purification was carried out on a Phenomenex Jupiter 10µ Proteo 90 Å (250 × 10 mm) 
column. Purification was carried out by RP-HPLC with a Shimadzu LC-8A, equipped 
with a SPD-M10 AV diode array detector using a Kinetex® 5µm C18 100 Å, AXIA 
Packed LC Column 50 x 21.2 mm, Ea column with a flow rate of 20 mLmin-1. Peptides 
were obtained with a purity >95%; yields were calculated based on the amount of 
peptide obtained after purification. 
 
Peptide Synthesis  
Peptides were synthesized on solid phase by Fmoc chemistry on the MBHA (0.54 
mmol/g) resin by consecutive deprotection, coupling and capping cycle.[29]  
Biotin-conjugated TL was obtained by removing the amino terminal Fmoc group and 
coupling the peptide with N-(+)-Biotinyl-6-aminohexanoic acid in DMF employing the 
following conditions: 10 equivalents of N-(+)-Biotinyl-6-aminohexanoic acid + 9.8 
equivalents of HATU (0.45 M in DMF)+ 14 equivalents of DIPEA; the solution was 
reacted with the peptide for 3 h at r.t. and double coupling was performed.  
Fluorescein conjugated TL was obtained by coupling to the N-terminus amino-acid 6-
fluorescein-5(6)-carboxamido]hexanoic acid dissolved in DMF; 5 equivalents of 6-
fluorescein-5(6)-carboxamido]hexanoic acid +4.98 equivalents of HOBT/ HBTU (0.45 
M in DMF)+ 7 equivalents of NMM were incubated with the peptide 3 h at r.t. in the 
dark. A double coupling was performed. All peptides were cleaved off the resin and 
deprotected by treatment with TFA/TIS/H2O 95/2.5/2.5 v/v/v, 90 min. TFA was 
concentrated and peptides were precipitated in cold ethylic ether. 
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Purification of the peptides was performed by semi-preparative RP-HPLC using a 
gradient of acetonitrile (0.1% TFA) in water (0.1% TFA) from 30 to 85% in 30 min. 
Products were lyophilized three times and the peptides were characterized by MALDI 
tandem mass spectrometry (MALDI-MS/MS). 
 
 
Bacterial cell growth and viability 
The minimum inhibitory concentration (MIC) of TL was measured by broth 
microdilution. The cell strain of E. coli BL21 was incubated overnight in Luria-­‐Bertani 
(LB) at 37°C. The culture was diluted to obtain a concentration of 0.08 OD600 / mL in 
fresh medium and grown at 37°C for 90 minutes.  At an OD/mL value of 0.5, 50 µl of 
bacterial suspension were added to ten wells and incubated with serial dilutions of the 
TL peptide from an initial concentration of 512 µM. The sterility control well contained 
100 µL of LB, while the growth control well contained 100 µL of microbial suspension.  
The MIC value of TL on E.coli cells was also calculated in the presence of 1mM GTP. 
E. coli cells were grown as previously described and the MIC was determined by the 
lowest concentration showing no visible growth after 24 h of incubation at 37°C by 
measuring the Abs at 600 nm. The assay was performed in triplicate.  
 
 
Membrane proteins extraction. 
E. coli cells were inoculated in 10 mL of liquid LB and placed at 37°C for 16 h under 
stirring. At the end of the incubation, bacterial cells were grown in 1L at 37°C under 
stirring for 3h. The pellet was recovered by centrifugation at 4°C for 15 minutes at 5000 
rpm and stored at -80°C.  
The cell pellet was resuspended in 5 mL of Cell Lysis Buffer (20 mM Tris-HCl pH 8.0  
500 mM NaCl, 4 mM DTT, 1 mM PMSF) and subjected to mechanical lysis by French 
Press. The sample was then centrifuged at 4°C for 30 minutes at 10000 rpm in order to 
remove the cell debris and the supernatant recovered was ultracentrifuged for 2 hours at 
4°C at 54,000 rpm. The obtained pellet was resuspended in solubilization buffer (50 
mM Tris-HCl pH 8.0, 500 mM NaCl, 10% Glicerol, 4 mM DTT, 1 mM PMSF, 6 mM 
3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)) under 
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stirring at 4°C for 16 h. The sample was again ultracentrifuged for 2 hours at 4°C at 
54,000 rpm. The supernatant containing cytosolic proteins was removed, while the 
membrane proteins were dissolved in solubilization buffer. 
 
Pull Down experiments 
The pull-down experiment was performed using 200 µL of dry avidin-conjugated 
agarose beads. The resin was divided in two portions, one portion was left unmodified 
and the second was incubated with a solution of 2 mg/mL of biotinylated TL for 30 
minutes at 4°C under stirring. The supernatant was then removed by centrifugation at 
4°C for 10 minutes at 3000 rpm and the resin equilibrated with 5 volumes of binding 
buffer at 4°C.  
About 2.5 mg of membrane proteins were incubated on free agarose beads at 4°C for 2h 
under stirring to remove possible non-specific binding, according to the pre-cleaning 
procedure. The supernatant containing the unbound membrane proteins was recovered 
by centrifugation at 4°C for 10 minutes at 3000 rpm and then incubated on agarose 
beads with the immobilized peptide for 3h at 4°C under stirring. Beads were washed 
with 5 volumes of binding buffer and the peptide-interacting proteins were released by 
competitive elution with 500 µL of elution buffer containing an excess of biotin for 1h 
at 4°C under stirring. 
TL putative protein interactors were fractionated by SDS-PAGE. Protein bands from 
sample and control lanes were excised from the gel and subjected to in situ hydrolysis 
with trypsin. The resulting peptide mixtures were analyzed by Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS) using a LTQ Orbitrap 
XLOrbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) and the 
data obtained were used to search for a non-redundant protein database using an in 
house version of the Mascot software leading to identification of the putative AMP 
protein interactors. The putative peptide interactors were gathered within functional 
pathways by bioinformatic tools (DAVID, KEGG, STRING). 
 
Docking calculations 
The putative binding site of TL on FtsZ was determined using docking calculations. The 
structure of Ftsz has been modelled using SwissProt Model Server and the chain A of 
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the structure of the protein from P. aeruginosa (2VAW, 60% sequence identity) as 
starting model.[30, 31] The NMR structure of TL was kindly provided by Prof. 
Bhattacharjya.[19] The peptide adopts an α-helix structure, in good agreement with 
CD spectra collected in solution.[32] Interestingly, PEP-FOLD3 also predicts a helical 
structure for this peptide.[33] 
The model of the FtsZ-TL complex was obtained using FTDOCKs.[34] The structure of 
the complex was then energy minimized and refined using Flexpeptdock .[35] We have 
verified that the peptide binding site was predicted also by other docking programs and 
indeed the peptide binding site was predicted also by PEPDOCK and 
SWARMDOCK.[36, 37] Analysis of the structure was performed using Coot, figures 
were generated with PyMol (www.pymol.org).[38] 
 
Expression of Escherichia coli FtsZ and enzymatic assay 
Untagged E. coli FtsZ was expressed from pET28a in BL21 cells. Cells were grown at 
37  °C in 200 mL of LB culture media with 50µg/mL kanamycin and 0.4 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG) was added at an optical density of ∼0.5 at 600 
nm. The culture was grown for 90 min at 37°C for FtsZ production. Cells were 
harvested by centrifugation (5000 rpm , 15 min at 4  °C), and pellets were resuspended 
in Tris glycerol buffer (Tris glycerol buffer, 50 mM Tris-HCl, 50 mM KCl, 1 mM 
EDTA, 10% glycerol, pH 8.0) and were lysed on ice using a sonicator. The soluble 
fraction, containing the FtsZ protein, was separated from the cell debris by 
centrifugation (100,000 × g for 2 h at 4  °C). 
The protein from the soluble fraction was precipitated with 30% ammonium sulfate for 
16h. The sample was centrifuged (10000 rpm for 35 min at 4  °C), and the pellet was 
resuspended in 5 ml Tris glycerol buffer, pH 8.0 and dialyzed to remove the ammonium 
sulfate. The sample was purified by anion exchange chromatography using a Mono-Q 
HR 5/5 column equilibrated with Tris glycerol buffer, pH 8.0. FtsZ was retained on the 
column and was eluted with a 0–100% gradient of 1 M NaCl in the same buffer.[39] 
Protein concentration was estimated with Bradford reagent (Bio-Rad protein assay), 
protein purity was assessed by SDS- polyacrylamide gel electrophoresis (SDS-PAGE) 
and characterized by mass mapping using MALDI-MS/MS. 
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The activity of FtsZ on GTP substrate was determined with an enzymatic assay using 
BIOMOL® Green phosphate reagent (Biomol). Initially, FtsZ (6 µM) was incubated in 
25 mM PIPES/NaOH, pH 6.8 for 30 minutes at 30°C. The enzyme was then treated 
with different concentrations of GTP, ranging from 0 µM to 250 µM, either in the 
absence or in the presence of 35 µM TL. The reaction was performed for 10 min and 
then stopped by addition of 100 µl BIOMOL® Green reagent and the increase in 
absorbance at 620 nm was measured following 25 min incubation. The experiment was 
performed in duplicate. Kinetic parameters were fitted by non-linear regression with 
GraphPad Prism 4Project. The half-maximal inhibitory concentration (IC50) of TL on 
the GTPase activity of FtsZ was calculated by plotting the percentage of enzymatic 
activity versus the logarithm of TL concentration. 
 
Binding experiment 
Fluorescence experiments were performed at 25 °C in a 250µL quartz cuvettes (Hellma, 
Germany) on a VARIAN Cary Eclipse Fluorimeter. Titrations were carried out in 50 
mM Tris-HCl buffer pH 7.2, 1M NaCl. Fluo-TL was excited at 440 nm (slit 5 nm) and 
the emission was monitored at 520 nm (slit 5 nm) without and in the presence of 
increasing concentrations of FtsZ protein (from 0.003 to 0.121µM) in a High Voltage 
mode. The peptide and the protein were dissolved at a 1.5 µM concentration. All 
experiments were repeated in duplicate. The change in the fluorescence intensity of the 
reaction set was fit into “one site-specific binding” equation of GraphPad Prism 5 
(GraphPad Software).  
 
Optical Microscopy and TEM analyses 
E. coli cells were inoculated in 10 mL of liquid LB and placed at 37°C for 16 h under 
stirring. At the end of the incubation, bacterial cells grown to 0.5 OD/mL were 
incubated with 20 µM TL and allowed to grow for a further 5 h. A similar bacterial 
growth was prepared and used as control in the absence of the peptide. Samples of 100 
µL were observed by optical microscope using a ZEISS optical microscope for phase 
contrast and 50X magnifications. 
For TEM analysis, E. coli cells were treated with sub-MIC concentration of TL for 1h at 
37°C. After incubation, bacterial cells were centrifugated at 3000 rpm for 15min, 
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washed with PBS and resuspended in PBS containing 2.5% glutaraldehyde to fix the 
cells. Samples (10µl) were applied to a glow discharged formvar/carbon film copper 
mesh grid and led to adsorb for 2 minutes. The excess liquid was eliminated with water 
and the sample was stained with 1% uranyl acetate allowing the grids to dry before 
TEM analyses. TEM analyses were carried out on a JEOL JEM-1400 TEM with an 
accelerating voltage of 120kV. Digital images were collected with an EMSIS Xarosa 
digital camera with Radius software.  
 
Scattering Measurements 
E. coli cells were grown to 0.5 OD/mL in the presence and in the absence of 20 µM TL 
up to 1 OD at 600 nm. Cells were then centrifuged at 5000 rpm for 15 min, treated with 
0.4% paraformaldehyde for 10 min, washed with deuterated PBS1X for three times and 
the samples were finally resuspended in deuterated PBS1X. 
Dynamic Light Scattering (DLS) measurements were performed by using a home-made 
instrument composed by a Photocor compact goniometer, a SMD 6000 Laser Quantum 
50 mW light source operating at 532.5 nm, a photomultiplier (PMT-120-OP/B) and a 
correlator (Flex02-01D) from Correlator.com.[40, 41] All measurements were 
performed at 25 °C with the temperature controlled through the use of a thermostat bath. 
All the measurements were performed in triplicate at fixed scattering angle of 90°. 
 
Small Angle Neutron Scattering (SANS) measurements were performed at 25 °C with 
the KWS-2 diffractometer operated by Julich Centre for Neutron Science at the FRMII 
source located at the Heinz Maier Leibnitz Centre, Garching (Germany). For all the 
samples, neutrons with a wavelength of 7 Å and Δλ/λ ≤ 0.1 were used. A two-
dimensional array detector at three different wavelength (W)/collimation (C)/sample-to-
detector (D) distance combinations (W 7 Å/C 8 m/D 2 m, W 7 Å/C 8 m/D 8 m, and W 7 
Å/C 20 m/ D 20 m) measured neutrons scattered from the samples. These 
configurations allowed collecting data in a range of the scattering vector modulus q 
between 0.002 Å−1 and 0.4 Å−1.  
The USANS measurements were performed on KWS-3 at 25 °C. The sample-to-
detector distances was 9.5 m with a wavelengths of 5Å (Δλ/λ = 10%) and 12.8 Å (Δλ/λ 
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= 20%), respectively. Both in the case of KWS2 and KWS3 measurements a 1 mm 
Helma quartz cells were used.  
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Supplementary Figure 1.  
Determination of TL minimum inhibitory concentration (MIC). E. coli cells were grown 
in the presence of serial dilution of TL from 512 µM to 0.5 µM and MIC was 
determined by the lowest concentration showing no visible growth after 24h of 
incubation at 37°C. The error bars on the graphs stand for the standard deviation from 
the mean of 3 experiments. One way ANOVA statistical test using Graph pad prism 
software was performed, p < 0.0001. 
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